Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.73
+6.48%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
18.45x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.50x
Price / sales
—
Price / cash flow
-1.12x

Enterprise value

Enterprise value
-$117.4M
EV / sales
—
EV / EBITDA
0.89x
EV / EBIT
25.07x
Market cap
$115.6M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026